42 – Asthma: Clinical Diagnosis and Management

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-1-4557-3383-5.00042-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of respiratory muscles in the hyperinflation of bronchial asthma.

  2015cited by this paper
• Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.

  2014cited by this paper
• Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.

  2014cited by this paper
• Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma.

  2014cited by this paper
• Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma

  2014cited by this paper
• Bronchial thermoplasty: reappraising the evidence (or lack thereof).

  2014cited by this paper
• The role of venous blood gas in the Emergency Department: a systematic review and meta-analysis

  2014cited by this paper
• Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

  2013cited by this paper
• Detection of the Airway Obstruction Stage in Asthma Using Impulse Oscillometry System

  2013cited by this paper
• The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis.

  2013cited by this paper
• Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review.

  2013cited by this paper
• International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

  2013cited by this paper
• Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.

  2013cited by this paper
• Complex phenotypes in asthma: current definitions.

  2013cited by this paper
• Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

  2013cited by this paper
• Predictors of response to tiotropium versus salmeterol in asthmatic adults.

  2013cited by this paper
• Dupilumab in persistent asthma with elevated eosinophil levels.

  2013cited by this paper
• Targeting the small airways asthma phenotype: if we can reach it, should we treat it?

  2013cited by this paper
• Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.

  2012cited by this paper
• Risk factors and characteristics of respiratory and allergic phenotypes in early childhood.

  2012cited by this paper
• Relating small airways to asthma control by using impulse oscillometry in children.

  2012cited by this paper
• History of Symptom Triggers in Patients Presenting to the Emergency Department for Asthma

  2012cited by this paper
• Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?

  2012cited by this paper
• Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

  2012cited by this paper
• An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

  2012cited by this paper
• Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.

  2012cited by this paper
• Update in asthma 2011.

  2012cited by this paper
• A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

  2012cited by this paper
• Computed tomography scans in severe asthma: utility and clinical implications

  2012cited by this paper
• Severe asthma: advances in current management and future therapy.

  2012cited by this paper
• Severe asthma: from characteristics to phenotypes to endotypes

  2012cited by this paper
• Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

  2012cited by this paper
• Asthma outcomes: biomarkers.

  2012cited by this paper
• Asthma: Vocal Cord Dysfunction (VCD) and other Dysfunctional Breathing Disorders

  2012cited by this paper
• Asthma outcomes: exacerbations.

  2012cited by this paper
• Cluster Analysis of Obesity and Asthma Phenotypes

  2012cited by this paper
• A study of the use of impulse oscillometry in the evaluation of children with asthma: Analysis of lung parameters, order effect, and utility compared with spirometry

  2012cited by this paper
• Asthma exacerbations: Origin, effect, and prevention

  2011cited by this paper
• Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

  2011cited by this paper
• Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma

  2011cited by this paper
• Decreased response to inhaled steroids in overweight and obese asthmatic children.

  2011cited by this paper
• Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.

  2011cited by this paper
• Lebrikizumab treatment in adults with asthma.

  2011cited by this paper
• Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children—not too much, not too little

  2011cited by this paper
• Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.

  2011cited by this paper
• Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?

  2011cited by this paper
• Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome.

  2011cited by this paper
• Inhaled corticosteroid dosing: double for nothing?

  2011cited by this paper
• Asthma phenotypes and interleukin-13--moving closer to personalized medicine.

  2011cited by this paper
• Daily or intermittent budesonide in preschool children with recurrent wheezing.

  2011cited by this paper
• Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.

  2010cited by this paper
• Vocal cord dysfunction: beyond severe asthma.

  2010cited by this paper
• A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)

  2010cited by this paper
• Diagnostic criteria for the classification of vocal cord dysfunction.

  2010cited by this paper
• Clinical practice. Emergency treatment of asthma.

  2010cited by this paper
• Overall asthma control: the relationship between current control and future risk.

  2010cited by this paper
• Predicting Response to Inhaled Corticosteroid Efficacy (PRICE Trial)

  2010cited by this paper
• Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance.

  2010cited by this paper
• Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.

  2010cited by this paper
• A trial of clarithromycin for the treatment of suboptimally controlled asthma.

  2010cited by this paper
• Qualitative analysis of high-resolution CT scans in severe asthma.

  2009cited by this paper
• Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

  2009cited by this paper
• Efficacy of esomeprazole for treatment of poorly controlled asthma.

  2009cited by this paper
• Silent acid reflux and asthma control.

  2009cited by this paper
• Novel targets of therapy in asthma

  2009cited by this paper
• Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

  2009cited by this paper
• Occupational asthma: current concepts in pathogenesis, diagnosis, and management.

  2009cited by this paper
• Asthma: an imaging update.

  2009cited by this paper
• Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.

  2009cited by this paper
• Improvements with tiotropium in COPD patients with concomitant asthma.

  2008cited by this paper
• Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients

  2008cited by this paper
• Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes

  2008cited by this paper
• Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation.

  2008cited by this paper
• Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype

  2008cited by this paper
• Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology.

  2008cited by this paper
• Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

  2008cited by this paper
• Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.

  2008cited by this paper
• Global strategy for asthma management and prevention: GINA executive summary

  2008cited by this paper
• Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement.

  2008cited by this paper
• Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma.

  2008cited by this paper
• Severe exacerbations predict excess lung function decline in asthma

  2007cited by this paper
• Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• The role of chest radiography and computed tomography in the diagnosis and management of asthma

  2007cited by this paper
• Reference ranges for exhaled nitric oxide derived from a random community survey of adults.

  2007cited by this paper
• Cost‐effectiveness of omalizumab in patients with severe persistent allergic asthma

  2007cited by this paper
• Randomized comparison of strategies for reducing treatment in mild persistent asthma.

  2007cited by this paper
• Predicting and evaluating response to omalizumab in patients with severe allergic asthma.

  2007cited by this paper
• Correlation between spirometry and impulse oscillometry in children with asthma

  2007cited by this paper
• American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis.

  2007cited by this paper
• Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

  2007cited by this paper
• Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

  2007cited by this paper
• Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.

  2007cited by this paper
• Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

  2007cited by this paper
• Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

  2007cited by this paper
• A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

  2007cited by this paper
• Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.

  2007cited by this paper
• Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.

  2007cited by this paper
• The demise of anti IL-5 for asthma, or not.

  2007cited by this paper
• Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease.

  2007cited by this paper

• ANALYSIS OF TUBERCULIN SKIN TEST IN ADULT ASTHMATIC PATIENTS USING STEROIDS AS PART OF THEIR MANAGEMENT

  2018cites this paper